Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Ranke

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Frontiers in Endocrinology|December 8, 2022
Clinical, genetic, and epidemiological survey of Polish children and adolescents with severe obesity: A study protocol of the Polish-German study project on severe early-onset obesityMagdalena Mierzwa, Mirosław Bik-Multanowski, Michael B Ranke, et al.
Viruses|December 2, 2020
Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 PatientsBertram Flehmig, Michael Schindler, Natalia Ruetalo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformityGerhard Binder, Alexandra Renz, Alicia Martinez, et al.
Journal of Clinical Medicine|October 16, 2024
Factors beyond Body Mass Index Associated with Cardiometabolic Risk among Children with Severe ObesityEwa Kostrzeba, Mirosław Bik-Multanowski, Stephanie Brandt, et al.
Hormone Research|May 2, 2009
Network of European studies of genes in growth (NESTEGG)Linda B Johnston, Wiestske Ester, Janina Caliebe, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2008
Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassaysMichael P Brugts, Michael B Ranke, Leo J Hofland, et al.
Human Reproduction (Oxford, England)|February 8, 2005
Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001Helmuth G Doerr, Markus Bettendorf, Berthold P Hauffa, et al.
European Journal of Pediatrics|June 14, 2024
The age of the obesity onset is a very important factor for the development of metabolic complications and cardiovascular risk in children and adolescents with severe obesityEwa Szczudlik, Anna Stępniewska, Mirosław Bik-Multanowski, et al.
Pediatric Research|January 11, 2007
Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGSMichael B Ranke, Anders Lindberg, Angel Ferrández Longás, et al.
Hormone Research in Paediatrics|May 11, 2012
IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature)Janina Caliebe, Sander Broekman, Merel Boogaard, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Frontiers in Endocrinology|December 8, 2022
Clinical, genetic, and epidemiological survey of Polish children and adolescents with severe obesity: A study protocol of the Polish-German study project on severe early-onset obesityMagdalena Mierzwa, Mirosław Bik-Multanowski, Michael B Ranke, et al.
Viruses|December 2, 2020
Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 PatientsBertram Flehmig, Michael Schindler, Natalia Ruetalo, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformityGerhard Binder, Alexandra Renz, Alicia Martinez, et al.
Journal of Clinical Medicine|October 16, 2024
Factors beyond Body Mass Index Associated with Cardiometabolic Risk among Children with Severe ObesityEwa Kostrzeba, Mirosław Bik-Multanowski, Stephanie Brandt, et al.
Hormone Research|May 2, 2009
Network of European studies of genes in growth (NESTEGG)Linda B Johnston, Wiestske Ester, Janina Caliebe, et al.
The Journal of Clinical Endocrinology and Metabolism|April 10, 2008
Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassaysMichael P Brugts, Michael B Ranke, Leo J Hofland, et al.
Human Reproduction (Oxford, England)|February 8, 2005
Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001Helmuth G Doerr, Markus Bettendorf, Berthold P Hauffa, et al.
European Journal of Pediatrics|June 14, 2024
The age of the obesity onset is a very important factor for the development of metabolic complications and cardiovascular risk in children and adolescents with severe obesityEwa Szczudlik, Anna Stępniewska, Mirosław Bik-Multanowski, et al.
Pediatric Research|January 11, 2007
Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGSMichael B Ranke, Anders Lindberg, Angel Ferrández Longás, et al.
Hormone Research in Paediatrics|May 11, 2012
IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature)Janina Caliebe, Sander Broekman, Merel Boogaard, et al.
Pageof 14